Dr Ronald Castelino

Experts / Dr Ronald Castelino

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

Dr Ronald Castelino is a Senior Lecturer at the University of Sydney, Faculty of Medicine and Health, School of Pharmacy. He is a practising renal pharmacist (Blacktown Hospital) with a track record in translational research relevant to renal medicine. He is also interested in health services research that focusses on developing interventions to improve medication safety and quality use of medicines.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

By Dr Ronald Castelino

Podcasts

Renal medicine

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

More from this expert

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

More from this expert

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.